The Eighth Circuit has drawn sharp criticism after judges were accused of distorting federal procedure to deliver a ruling favourable to the Trump administration. Legal commentators have labelled the judges involved as
Hargreaves Lansdown, one of the UK’s largest investment platforms, regularly publishes its outlook on the key events and company updates expected to move markets in the coming week. Investors across the UK
More
Teva Pharmaceuticals (TEVA) has emerged as the stalking horse bidder for bankrupt BioXcel Therapeutics’ neuroscience portfolio in a deal worth up to $125 million. Connecticut-based BioXcel filed for Chapter 11 bankruptcy protection
More
The amended defamation lawsuit filed by Donald Trump against the New York Times has expanded significantly, now running to 62 pages of legal arguments and claims. Despite the increased length, the suit
More
Consumer discretionary stocks attracted significant attention from traders during Friday’s intraday session, with eleven names showing notable price movement across the sector. The consumer discretionary sector is broadly sensitive to shifts in
More
The FTSE 250 index serves as the primary feeder for FTSE 100 promotion, with a handful of companies consistently edging closer to the top flight of London-listed equities. Quarterly index reviews by
More
Takeda Pharmaceutical (TAK) has secured FDA approval for Mimrylo, a first-of-its-kind therapy targeting polycythemia vera, a rare and potentially life-threatening blood cancer. Polycythemia vera affects approximately 90,000 people in the United States
More
U.S. Citizenship and Immigration Services has published a sweeping proposed rule that would dramatically raise the cost of hiring skilled foreign workers through the H-1B visa programme. The proposed rule, titled “Fee
More
European and US equity markets closed higher on Friday after Federal Reserve chairman Kevin Warsh issued a stark inflation warning that pushed rate-hike expectations sharply higher. London’s FTSE 100 index closed up
More
Broadcom (AVGO) earnings and the latest US jobs report are emerging as the two key tests for equity markets navigating a fragile rally. Investors have grown increasingly cautious heading into a data-heavy
More
Cencora, one of the largest pharmaceutical distributors in the United States, is deploying artificial intelligence to tackle persistent compliance gaps under the Drug Supply Chain Security Act. Gregg Gorniak, VP of manufacturer
More